This inventor holds 2 USPTO granted patents and 10 published patent applications. Top assignee: Solarea Bio, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Alicia Eve Ballok: Innovator in Immunomodulatory Compositions
Introduction
Alicia Eve Ballok is a prominent inventor based in Natick, MA (US). She has made significant contributions to the field of immunology through her innovative research and development of microbial compositions aimed at treating immune system disorders. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Alicia's latest patents focus on immunomodulatory compositions comprising microbial entities. These disclosures provide compositions, including pharmaceutical formulations, dietary supplements, medical foods, and food products, that utilize combinations of live microbe populations. The aim is to treat and prevent immune system disorders and conditions related to inflammation, addressing both pathogen-assisted conditions and those independent of pathogens. The patents also include methods for using these compositions and selecting appropriate microbial entities for formulation.
Career Highlights
Alicia is currently associated with Solarea Bio, Inc., where she continues to advance her research in immunomodulatory therapies. Her work is characterized by a commitment to improving health outcomes through innovative solutions.
Collaborations
Alicia collaborates with notable colleagues, including Eric Michael Schott and Gerardo V Toledo, who contribute to her research endeavors and the development of her patented technologies.
Conclusion
Alicia Eve Ballok is a trailblazer in the field of immunology, with her patents reflecting a dedication to enhancing immune health through innovative microbial compositions. Her contributions are significant in the ongoing quest for effective treatments for immune-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile